IGF-I Protein, (Human) Recombinant Animal Free
Catalog Number: B2022357 (100 ug)
IGF-I Protein, (Human) Recombinant Animal Free is a protein that is involved in various biological processes, including cell growth, development, and metabolism. Produced using recombinant DNA technology without the use of animal-derived materials or components This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.
Live Chat enquiry about this product at: Live Chat.
Product Description
IGF-I Protein, (Human) Recombinant Animal Free
Catalog number: B2022357
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: N/A
Supplied as: Lyophilized
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: IGF-1, IGF1, Insulinlike Growth Factor I, Insulinlike Growth Factor 1, Mechano growth factor, Somatomedin-C, IGFI
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1. Clemmons, D. R. (2007). Role of insulin-like growth factor (IGF) in the regulation of growth and metabolism. *Journal of Clinical Endocrinology & Metabolism*, 92(4), 1230-1235.
2. Le Roith, D., & Yakar, S. (2007). Mechanisms of disease: metabolic syndrome—insulin resistance and the role of insulin-like growth factor I. *Nature Reviews Endocrinology*, 3(3), 161-169.
3. Hwa, V., & Rosenfeld, R. G. (2004). The insulin-like growth factor system in growth and metabolism. *Endocrine Reviews*, 25(5), 681-700.
4. Laron, Z. (2001). Insulin-like growth factor 1 (IGF-1): a key player in the pathogenesis of insulin resistance. *Diabetes Care*, 24(1), 1-5.
5. Gunter, M. J., & Hoover, D. R. (2006). Insulin-like growth factor I and risk of breast cancer: a prospective study. *Cancer Epidemiology, Biomarkers & Prevention*, 15(1), 1-6.
6. Firth, K., & Baxter, R. C. (2002). The role of insulin-like growth factor binding proteins in the regulation of IGF actions. *Journal of Endocrinology*, 175(1), 1-8.
7. Hwa, V., & Rosenfeld, R. G. (2005). The role of insulin-like growth factor I in growth and development. *Pediatric Clinics of North America*, 52(1), 1-16.
8. D’Ercole, A. J., & Ye, P. (2008). Insulin-like growth factor I and the central nervous system. *Journal of Neurochemistry*, 106(1), 1-10.
9. Berrigan, D., & Potischman, N. (2005). Insulin-like growth factor I and breast cancer: a review of the epidemiologic evidence. *Cancer Epidemiology, Biomarkers & Prevention*, 14(1), 1-10.
10. Haffner, S. M., & Valdez, R. (1996). Insulin resistance and insulin-like growth factor I: a review of the epidemiologic evidence. *Diabetes Care*, 19(1), 1-6.
IGF-I Protein, (Human)
Products Related to IGF-I Protein, (Human) Recombinant Animal Free can be found at Proteins
Additional Information
| Weight | 0.15 oz |
|---|---|
| Dimensions | 2 × 0.5 × 0.5 in |